Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA.2/5 subvariants in the upper and lower respiratory tractBingjie Hu, Hin Chu, Shuofeng Yuan et al.|EBioMedicine|2023Cited by 22
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jie Zhou et al.|Nature Communications|2025Cited by 8
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Shengyong Yang, Jie Zhou et al.|Research Square|2024Cited by 1
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jie Zhou et al.|Nature Communications|2025Cited by 0